Skip to content
Archive

Tag: Ltd.

Business

Green Industry, Bright Future – Deye 2025 Dubai Distributor Summit Successfully Held

DUBAI, UAE, Dec. 5, 2025 /PRNewswire/ — In November 2025, Deye successfully hosted the “Green Industry, Bright Future — Deye…

News

SINEXCEL Receives Frost & Sullivan’s 2025 China Ultra-Fast and Megawatt Charging Competitive Strategy Leadership Recognition

SHENZHEN, China, Nov. 18, 2025 /PRNewswire/ — Frost & Sullivan has recognized SINEXCEL with the prestigious 2025 China Ultra-Fast and Megawatt…

News

JA Solar and 5B Sign Strategic Module Supply Agreement for 100MW+ Project in Western Australia

BEIJING, Oct. 30, 2025 /PRNewswire/ — JA Solar, a trusted global partner in green energy, and Australian solar innovator 5B…

PR Newswire

China Pavilion at Osaka Expo 2025 wins the Gold Award! Unilumin provides a comprehensive multimedia solution

OSAKA, Japan, Oct. 29, 2025 /PRNewswire/ — On the evening of October 12, 2025, the Osaka Expo 2025 witnessed a…

Business

AgiBot Robotics Debuted at IROS 2025, the AgiBot World Challenge Concluded Successfully

SHANGHAI, Oct. 30, 2025 /PRNewswire/ — From October 19 to 25, 2025, the 2025 IEEE/RSJ International Conference on Intelligent Robots…

Health

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

TAIPEI, Oct. 22, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food &…

Health

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

TAIPEI, Oct. 23, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food &…

Business

Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM

In the OptiTROP-Lung04 trial, a total of 376 patients were randomized (1:1) to receive sac-TMT monotherapy or chemotherapy. As at…

Business

Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

CHENGDU, China, Oct. 17, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s human epidermal growth factor receptor 2 (HER2)-directed…

PR Newswire

Linglong Tire’s 50th Anniversary Celebration Successfully Held in Madrid

MADRID, Oct. 15, 2025 /PRNewswire/ — Recently, the Linglong Tire 50th Anniversary Celebration was successfully held in Madrid. Over 200…